Category Archives: Levaquin

Featured Stories

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

FDA Panel Says Safety Warnings Inadequate for Fluoroquinolones

In a safety announcement issued on May 12, 2016, the U.S. Food and Drug Administration (FDA) announced label changes for fluoroquinolone drugs to warn of serious side effects associated with these drugs. The FDA says these risks generally outweigh the … Continue reading

Posted in Defective Products, Health Concerns, Levaquin, Pharmaceuticals |

FDA Omits Serious Side Effects From Levaquin Label, Update Urged

FDA Omits Serious Side Effects From Levaquin Label

The Food and Drug Administration (FDA) is facing pressure to amend the warning label of Levaquin and other antibiotics in its class to include serious and sometimes fatal side effects of the fluoroquinolones. Cleveland television station ABC5 (WEWS) obtained a … Continue reading

Posted in Cipro, Defective Products, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , |

FDA Report Indicates Levaquin, Other Similar Antibiotics May be Linked to Mitochondrial Toxicity

Levaquin & Other Antibiotics Linked to Mitochondrial Toxicity

Levaquin, Cipro and other medications are part of a family of antibiotics known as fluoroquinolones, which are commonly used to treat infections. In 2013, the U.S. Food and Drug Administration (FDA) added a black box warning, the agency’s most serious … Continue reading

Posted in Health Concerns, Legal News, Levaquin, Toxic Substances | Tagged , , , , , |

New Lawsuit Filed Against Janssen Pharmaceuticals Over Levaquin Nerve Damage

Lawsuit Filed Against (Levaquin) Janssen Pharmaceuticals

Janssen Pharmaceuticals and drug distributor McKeeson Corp. were hit with a lawsuit last week in Pennsylvania federal court by a Texas woman who says the companies failed to warn of known dangers of the antibiotic Levaquin, which she alleges caused … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , , |

FDA Failed to Warn Public of Serious Side Effect Linked to Antibiotic Levaquin

FDA Failed to Warn Public of Levaquin Side Effect

The Food and Drug Administration (FDA) failed to disclose a serious side effect associated with the family of antibiotics known as fluoroquinolones identified in a 2013 agency report. In an investigation, Cleveland television station ABC5 obtained a 2013 FDA report … Continue reading

Posted in Cipro, Defective Products, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , |

Antibiotics Linked with Increased Arrhythmias and Death Risk

A new study indicates that short-term treatment with the antibiotics azithromycin and levofloxacin may increase the risk of serious cardiac arrhythmias and death. Research has shown a relationship between azithromycin use and an increased risk of cardiovascular death and all-cause … Continue reading

Posted in Health Concerns, Levaquin, Pharmaceuticals, Zithromax |

Broad-spectrum Antibiotics Overused, Studies Say

overuse_antobiotics_wide_spectrum

Research from organizations including the American Academy of Pediatrics and the Centers for Disease Control and Prevention (CDC) urges doctors to limit the use of broad-spectrum antibiotics like Cipro (ciprofloxacin). Recent studies have shown that doctors are overprescribing broad-spectrum antibiotics, … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals, Zithromax |

Common Antibiotics Linked to Eye Damage Risk

antibiotic_eye_damage

A year after a Canadian research study showed a connection between commonly prescribed antibiotics and blindness-inducing eye damage, patients and physicians still aren’t reporting these reactions to Health Canada. An article in the latest Canadian Adverse Reaction Newsletter suggests that … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals |

FDA: Zithromax May Lead to Potentially Fatal Heart Rhythms

The U.S. Food & Drug Administration is warning the public that Zithromax (azithromycin), also known as Zmax can cause abnormal changes in the electrical activity of the heart. This may lead to a potentially fatal irregular heart rhythm. Patients at … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals, Zithromax |

Cipro, Levaquin, Avelox Linked to Dangerous Side Effects

Antibiotics such as Cipro, Levaquin, and Avelox have been linked to dangerous side effects. All three are in a class of antibiotic medications known as fluoroquinolones. According to The New York Times’ blog, Well, the strong antibiotic drugs in the … Continue reading

Posted in Levaquin, Pharmaceuticals | Tagged |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.